Clinical Trials for Hepatoblastoma

Find clinical trials for hepatoblastoma. Discover research opportunities and treatment options in your area.

11 Active Trials Found

Showing 11 trials on this page

Page 1 of 1

Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells

NCT ID: NCT06198296

This clinical trial is studying a new treatment for adults with certain types of solid tumors that have a specific protein called GPC3 on their surface. The researchers are using a special kind of ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Houston, Texas, United States

EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults

NCT ID: NCT03618381

This clinical trial is looking at a new type of treatment called EGFR806 CAR T Cell Immunotherapy for children and young adults with certain types of solid tumors that have returned or didn’t respo...

Recruiting

Phase: PHASE1 Type: interventional Locations: Seattle, Washington, United States

A Multi-institutional Study for Treatment of Children With Newly Diagnosed Hepatoblastoma Using a Modified PHITT Strategy

NCT ID: NCT04478292

This clinical trial is studying a new way to treat children with a type of liver cancer called hepatoblastoma, which is often diagnosed in young kids. The researchers are using a modified treatment...

Recruiting

Phase: PHASE3 Type: interventional Locations: Shanghai, Shanghai, China

A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer

NCT ID: NCT06521567

This clinical trial is studying a combination of two medications, cobolimab and dostarlimab, to find out the safest and most effective doses for children and young adults with advanced cancer, spec...

Recruiting

Phase: PHASE1 Type: interventional Locations: Roma, Lazio, Italy, Barcelona, , Spain +35 more

B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)

NCT ID: NCT04897321

The 3CAR trial is a research study looking at a new type of treatment called immunotherapy for children and young adults (up to 21 years old) with specific types of solid tumors, such as neuroblast...

Recruiting

Phase: PHASE1 Type: interventional Locations: Memphis, Tennessee, United States

ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma

NCT ID: NCT04634357

This clinical trial is studying a new treatment using ET140203 T-cells for children and young adults with certain types of liver cancer, including hepatoblastoma and hepatocellular carcinoma. The g...

Recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, San Francisco, California, United States

A French Multicenter Observational Retrospective Study of Rare Primary Liver Cancers

NCT ID: NCT06541652

This clinical trial is studying rare types of primary liver cancers, including conditions like hepatocholangiocarcinoma and fibrolamellar carcinoma. The goal is to gather information about the feat...

Recruiting

Type: observational Locations: Creteil, , France, Marseille, , France +38 more

Accurate Diagnosis and Grading of Pediatric Solid Tumors Based on Pathological Large Models

NCT ID: NCT06822842

This clinical trial is focused on improving the diagnosis of certain childhood cancers, specifically five types of solid tumors: neuroblastoma, medulloblastoma, Wilms tumor, hepatoblastoma, and rha...

Not yet recruiting

Type: observational

Molecular Basis of Pediatric Liver Cancer

NCT ID: NCT03959800

This clinical trial is focused on studying childhood liver cancer to better understand its genetic and molecular characteristics. The goal is to learn how these cancers develop and behave, which ca...

Recruiting

Type: observational Locations: Pittsburgh, Pennsylvania, United States

Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors

NCT ID: NCT04337177

This clinical trial is studying a new flavored oral medication called irinotecan VAL-413 (Orotecan®) combined with another drug called temozolomide to treat children and young adults with certain t...

Recruiting

Phase: PHASE1 Type: interventional Locations: Cincinnati, Ohio, United States, Nashville, Tennessee, United States +7 more

Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies

NCT ID: NCT04308330

This clinical trial is studying a new combination of drugs, including vorinostat, vincristine, irinotecan, and temozolomide, to see if they can effectively treat certain types of solid tumors and c...

Recruiting

Phase: PHASE1 Type: interventional Locations: Valhalla, New York, United States

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions